14.6.2022 | Business Kuopio

Marginum featured as one of rising stars in Kuopio start-up scene

Marginum Ltd, founded in autumn 2020, is developing next-generation technology for the removal of cancerous tumours. The innovation is based on years of scientific research.
 
The smart tissue monitor developed by the company detects cancer cells by utilising fluorescence. 

“The smart tissue monitor is used to improve treatments and reduce reoperations”, says Adjunct Professor and Resident in neurosurgery, Antti-Pekka Elomaa.

“The monitor is attached to the suction tube used by the surgeon to remove cancer cells. Based on intensity of detected fluorescence, the monitor detects cancer cells from surgical waste”, says CEO Samu Lehtonen
 
Initially, the monitor is to be used in the surgical treatment of brain cancer. The device improves the surgeon’s performance because cancer cells can be removed more accurately and damage to healthy tissue is avoided. Healthcare costs will decrease due to lesser need for reoperations.
 
Marginum is set to begin clinical trials with the smart tissue monitor in autumn. 
 
The original full article in Finnish can be read at Business Kuopio.

LATEST NEWS & PRESS

10.10.2022 | Kuopio Chamber of Commerce

TSLP winner Marginum increases the efficiency of cancer surgery

Marginum joins Kuopio Chamber of Commerce and the Finnish Startup Community after winning Tahko Ski Lift Pitch 2022.

4.10.2022 | University of Eastern Finland

Marginum selected by University of Eastern Finland to Stage Two

Marginum has been nominated by University of Eastern Finland (UEF) to participate at Stage Two competition in Berlin.

13.9.2022 | Kuopio Health

Smart tissue monitor helps the surgeon to identify cancer cells

Marginum joined Kuopio Health to further connect with research institutions and other member companies in the medical technology industry. 

6.9.2022 | Tekniikka&Talous

New device developed in Finland detects cancer better than surgeon

Cancerous tissue could be completely removed in the first operation. In this story, we’ll tell you what Marginum’s device is all about.

14.6.2022 | Business Kuopio

Marginum featured as one of rising stars in Kuopio start-up scene

Marginum Ltd, founded in autumn 2020, is developing next-generation technology for the removal of cancerous tumours.

27.4.2022 | Finnish Medical Journal

Smart tissue monitor detects cancer tissues from surgical waste

Precision techniques such as Marginum’s aspirate tissue monitoring enable unprecedently efficient identification of cancer tissue and the best possible treatment.